RVPH
NASDAQ · Pharmaceuticals
Reviva Pharmaceuticals Holdi
$0.81
-0.08 (-8.81%)
Open$0.91
Previous Close$0.89
Day High$0.92
Day Low$0.81
52W High$23.40
52W Low$0.67
Volume—
Avg Volume1.29M
Market Cap4.79M
P/E Ratio—
EPS$-0.47
SectorPharmaceuticals
Analyst Ratings
Strong Buy
12 analysts
Price Target
+1,419.1% upside
Current
$0.81
$0.81
Target
$12.37
$12.37
$10.29
$12.37 avg
$18.62
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 8.36M | 8.56M | 9.00M |
| Net Income | 1.57M | 1.65M | 1.70M |
| Profit Margin | 18.8% | 19.3% | 18.9% |
| EBITDA | 1.64M | 1.79M | 2.00M |
| Free Cash Flow | 1.45M | 1.55M | 1.35M |
| Rev Growth | +3.9% | +2.6% | +16.0% |
| Debt/Equity | 0.31 | 0.31 | 0.40 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |